カテゴリ： 世界, 医療/バイオ, QYResearch

DTPワクチンの世界市場2023年：百日咳、ジフテリア、破傷風

■ 英語タイトル：Global DTP Vaccine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8747）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8747
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[DTPワクチンの世界市場2023年：百日咳、ジフテリア、破傷風]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はDTPワクチンのグローバル市場について調査・分析し、世界のDTPワクチン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（百日咳、ジフテリア、破傷風）、用途別セグメント分析（病院、防疫所、保健所）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、SANOFI PASTEUR、NOVARTIS、Vaxelis、GSK、Serum Institute of India、Johnson & Johnson、Merck Sharp & Dohme Corp、Seqirus、Pfizer、Astrazeneca、astellas、Emergent BioSolutions Inc、WALVAX、Wuhan Institute of Biological Products Co.,Ltd.、Chengdu Institute of Biological Products Co.,Ltd.などが含まれています。DTPワクチンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、DTPワクチン市場規模を算出する際に考慮しました。

・DTPワクチン市場の概要
- 製品の定義
- DTPワクチンの種類別セグメント
- 世界のDTPワクチン市場規模：タイプ別分析（百日咳、ジフテリア、破傷風）
- DTPワクチンの用途別セグメント
- 世界のDTPワクチン市場規模：用途別分析（病院、防疫所、保健所）
- 世界のDTPワクチン市場規模予測（2018年-2029年）
- DTPワクチンの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- DTPワクチン市場の競争状況およびトレンド

・DTPワクチンの地域別市場規模
- 北米のDTPワクチン市場規模（2018年-2029年）
- 米国のDTPワクチン市場規模（2018年-2029年）
- ヨーロッパのDTPワクチン市場規模（2018年-2029年）
- アジア太平洋のDTPワクチン市場規模（2018年-2029年）
- 中国のDTPワクチン市場規模（2018年-2029年）
- 日本のDTPワクチン市場規模（2018年-2029年）
- 韓国のDTPワクチン市場規模（2018年-2029年）
- インドのDTPワクチン市場規模（2018年-2029年）
- オーストラリアのDTPワクチン市場規模（2018年-2029年）
- 中南米のDTPワクチン市場規模（2018年-2029年）
- 中東・アフリカのDTPワクチン市場規模（2018年-2029年）

・種類別セグメント：百日咳、ジフテリア、破傷風
- 世界のDTPワクチンのタイプ別販売量（2018年-2023年）
- 世界のDTPワクチンのタイプ別売上（2018年-2023年）
- 世界のDTPワクチンのタイプ別価格

・用途別セグメント：病院、防疫所、保健所
- 世界のDTPワクチンの用途別販売量（2018年-2023年）
- 世界のDTPワクチンの用途別売上（2018年-2023年）
- 世界のDTPワクチンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
SANOFI PASTEUR、NOVARTIS、Vaxelis、GSK、Serum Institute of India、Johnson & Johnson、Merck Sharp & Dohme Corp、Seqirus、Pfizer、Astrazeneca、astellas、Emergent BioSolutions Inc、WALVAX、Wuhan Institute of Biological Products Co.,Ltd.、Chengdu Institute of Biological Products Co.,Ltd.

・産業チェーンと販売チャネルの分析
- DTPワクチン産業チェーン分析
- DTPワクチンの主要原材料
- DTPワクチンの販売チャネル
- DTPワクチンのディストリビューター
- DTPワクチンの主要顧客

・DTPワクチン市場ダイナミクス
- DTPワクチンの業界動向
- DTPワクチン市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global DTP Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for DTP Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for DTP Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of DTP Vaccine include SANOFI PASTEUR, NOVARTIS, Vaxelis, GSK, Serum Institute of India, Johnson & Johnson, Merck Sharp & Dohme Corp, Seqirus and Pfizer, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DTP Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DTP Vaccine.
The DTP Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global DTP Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DTP Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
SANOFI PASTEUR
NOVARTIS
Vaxelis
GSK
Serum Institute of India
Johnson & Johnson
Merck Sharp & Dohme Corp
Seqirus
Pfizer
Astrazeneca
astellas
Emergent BioSolutions Inc
WALVAX
Wuhan Institute of Biological Products Co.,Ltd.
Chengdu Institute of Biological Products Co.,Ltd.
Segment by Type
Pertussis
Diphtheria
Tetanus
Segment by Application
Hospital
Epidemic Prevention Station
Village Health Room
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DTP Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DTP Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 DTP Vaccine Market Overview
1.1 Product Overview and Scope of DTP Vaccine
1.2 DTP Vaccine Segment by Type
1.2.1 Global DTP Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Pertussis
1.2.3 Diphtheria
1.2.4 Tetanus
1.3 DTP Vaccine Segment by Application
1.3.1 Global DTP Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Epidemic Prevention Station
1.3.4 Village Health Room
1.4 Global DTP Vaccine Market Size Estimates and Forecasts
1.4.1 Global DTP Vaccine Revenue 2018-2029
1.4.2 Global DTP Vaccine Sales 2018-2029
1.4.3 Global DTP Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 DTP Vaccine Market Competition by Manufacturers
2.1 Global DTP Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global DTP Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global DTP Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global DTP Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of DTP Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DTP Vaccine, Product Type & Application
2.7 DTP Vaccine Market Competitive Situation and Trends
2.7.1 DTP Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DTP Vaccine Players Market Share by Revenue
2.7.3 Global DTP Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DTP Vaccine Retrospective Market Scenario by Region
3.1 Global DTP Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global DTP Vaccine Global DTP Vaccine Sales by Region: 2018-2029
3.2.1 Global DTP Vaccine Sales by Region: 2018-2023
3.2.2 Global DTP Vaccine Sales by Region: 2024-2029
3.3 Global DTP Vaccine Global DTP Vaccine Revenue by Region: 2018-2029
3.3.1 Global DTP Vaccine Revenue by Region: 2018-2023
3.3.2 Global DTP Vaccine Revenue by Region: 2024-2029
3.4 North America DTP Vaccine Market Facts & Figures by Country
3.4.1 North America DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America DTP Vaccine Sales by Country (2018-2029)
3.4.3 North America DTP Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe DTP Vaccine Market Facts & Figures by Country
3.5.1 Europe DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe DTP Vaccine Sales by Country (2018-2029)
3.5.3 Europe DTP Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DTP Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific DTP Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific DTP Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America DTP Vaccine Market Facts & Figures by Country
3.7.1 Latin America DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America DTP Vaccine Sales by Country (2018-2029)
3.7.3 Latin America DTP Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DTP Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa DTP Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa DTP Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa DTP Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DTP Vaccine Sales by Type (2018-2029)
4.1.1 Global DTP Vaccine Sales by Type (2018-2023)
4.1.2 Global DTP Vaccine Sales by Type (2024-2029)
4.1.3 Global DTP Vaccine Sales Market Share by Type (2018-2029)
4.2 Global DTP Vaccine Revenue by Type (2018-2029)
4.2.1 Global DTP Vaccine Revenue by Type (2018-2023)
4.2.2 Global DTP Vaccine Revenue by Type (2024-2029)
4.2.3 Global DTP Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global DTP Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global DTP Vaccine Sales by Application (2018-2029)
5.1.1 Global DTP Vaccine Sales by Application (2018-2023)
5.1.2 Global DTP Vaccine Sales by Application (2024-2029)
5.1.3 Global DTP Vaccine Sales Market Share by Application (2018-2029)
5.2 Global DTP Vaccine Revenue by Application (2018-2029)
5.2.1 Global DTP Vaccine Revenue by Application (2018-2023)
5.2.2 Global DTP Vaccine Revenue by Application (2024-2029)
5.2.3 Global DTP Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global DTP Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 SANOFI PASTEUR
6.1.1 SANOFI PASTEUR Corporation Information
6.1.2 SANOFI PASTEUR Description and Business Overview
6.1.3 SANOFI PASTEUR DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 SANOFI PASTEUR DTP Vaccine Product Portfolio
6.1.5 SANOFI PASTEUR Recent Developments/Updates
6.2 NOVARTIS
6.2.1 NOVARTIS Corporation Information
6.2.2 NOVARTIS Description and Business Overview
6.2.3 NOVARTIS DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 NOVARTIS DTP Vaccine Product Portfolio
6.2.5 NOVARTIS Recent Developments/Updates
6.3 Vaxelis
6.3.1 Vaxelis Corporation Information
6.3.2 Vaxelis Description and Business Overview
6.3.3 Vaxelis DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Vaxelis DTP Vaccine Product Portfolio
6.3.5 Vaxelis Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK DTP Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute of India DTP Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson DTP Vaccine Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck Sharp & Dohme Corp
6.6.1 Merck Sharp & Dohme Corp Corporation Information
6.6.2 Merck Sharp & Dohme Corp Description and Business Overview
6.6.3 Merck Sharp & Dohme Corp DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Sharp & Dohme Corp DTP Vaccine Product Portfolio
6.7.5 Merck Sharp & Dohme Corp Recent Developments/Updates
6.8 Seqirus
6.8.1 Seqirus Corporation Information
6.8.2 Seqirus Description and Business Overview
6.8.3 Seqirus DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Seqirus DTP Vaccine Product Portfolio
6.8.5 Seqirus Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer DTP Vaccine Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Astrazeneca
6.10.1 Astrazeneca Corporation Information
6.10.2 Astrazeneca Description and Business Overview
6.10.3 Astrazeneca DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Astrazeneca DTP Vaccine Product Portfolio
6.10.5 Astrazeneca Recent Developments/Updates
6.11 astellas
6.11.1 astellas Corporation Information
6.11.2 astellas DTP Vaccine Description and Business Overview
6.11.3 astellas DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 astellas DTP Vaccine Product Portfolio
6.11.5 astellas Recent Developments/Updates
6.12 Emergent BioSolutions Inc
6.12.1 Emergent BioSolutions Inc Corporation Information
6.12.2 Emergent BioSolutions Inc DTP Vaccine Description and Business Overview
6.12.3 Emergent BioSolutions Inc DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Emergent BioSolutions Inc DTP Vaccine Product Portfolio
6.12.5 Emergent BioSolutions Inc Recent Developments/Updates
6.13 WALVAX
6.13.1 WALVAX Corporation Information
6.13.2 WALVAX DTP Vaccine Description and Business Overview
6.13.3 WALVAX DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 WALVAX DTP Vaccine Product Portfolio
6.13.5 WALVAX Recent Developments/Updates
6.14 Wuhan Institute of Biological Products Co.,Ltd.
6.14.1 Wuhan Institute of Biological Products Co.,Ltd. Corporation Information
6.14.2 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Description and Business Overview
6.14.3 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product Portfolio
6.14.5 Wuhan Institute of Biological Products Co.,Ltd. Recent Developments/Updates
6.15 Chengdu Institute of Biological Products Co.,Ltd.
6.15.1 Chengdu Institute of Biological Products Co.,Ltd. Corporation Information
6.15.2 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Description and Business Overview
6.15.3 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product Portfolio
6.15.5 Chengdu Institute of Biological Products Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DTP Vaccine Industry Chain Analysis
7.2 DTP Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DTP Vaccine Production Mode & Process
7.4 DTP Vaccine Sales and Marketing
7.4.1 DTP Vaccine Sales Channels
7.4.2 DTP Vaccine Distributors
7.5 DTP Vaccine Customers
8 DTP Vaccine Market Dynamics
8.1 DTP Vaccine Industry Trends
8.2 DTP Vaccine Market Drivers
8.3 DTP Vaccine Market Challenges
8.4 DTP Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global DTP Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global DTP Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global DTP Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global DTP Vaccine Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global DTP Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global DTP Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global DTP Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market DTP Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of DTP Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of DTP Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of DTP Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of DTP Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DTP Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DTP Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DTP Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global DTP Vaccine Sales by Region (2018-2023) & (Units)
Table 18. Global DTP Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global DTP Vaccine Sales by Region (2024-2029) & (Units)
Table 20. Global DTP Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global DTP Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global DTP Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global DTP Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global DTP Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America DTP Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America DTP Vaccine Sales by Country (2018-2023) & (Units)
Table 27. North America DTP Vaccine Sales by Country (2024-2029) & (Units)
Table 28. North America DTP Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America DTP Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe DTP Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe DTP Vaccine Sales by Country (2018-2023) & (Units)
Table 32. Europe DTP Vaccine Sales by Country (2024-2029) & (Units)
Table 33. Europe DTP Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe DTP Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific DTP Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific DTP Vaccine Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific DTP Vaccine Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific DTP Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific DTP Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America DTP Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America DTP Vaccine Sales by Country (2018-2023) & (Units)
Table 42. Latin America DTP Vaccine Sales by Country (2024-2029) & (Units)
Table 43. Latin America DTP Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America DTP Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa DTP Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa DTP Vaccine Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa DTP Vaccine Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa DTP Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa DTP Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global DTP Vaccine Sales (Units) by Type (2018-2023)
Table 51. Global DTP Vaccine Sales (Units) by Type (2024-2029)
Table 52. Global DTP Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global DTP Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global DTP Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global DTP Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global DTP Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global DTP Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global DTP Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global DTP Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global DTP Vaccine Sales (Units) by Application (2018-2023)
Table 61. Global DTP Vaccine Sales (Units) by Application (2024-2029)
Table 62. Global DTP Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global DTP Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global DTP Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global DTP Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global DTP Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global DTP Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global DTP Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global DTP Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. SANOFI PASTEUR Corporation Information
Table 71. SANOFI PASTEUR Description and Business Overview
Table 72. SANOFI PASTEUR DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. SANOFI PASTEUR DTP Vaccine Product
Table 74. SANOFI PASTEUR Recent Developments/Updates
Table 75. NOVARTIS Corporation Information
Table 76. NOVARTIS Description and Business Overview
Table 77. NOVARTIS DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. NOVARTIS DTP Vaccine Product
Table 79. NOVARTIS Recent Developments/Updates
Table 80. Vaxelis Corporation Information
Table 81. Vaxelis Description and Business Overview
Table 82. Vaxelis DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Vaxelis DTP Vaccine Product
Table 84. Vaxelis Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GSK DTP Vaccine Product
Table 89. GSK Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Serum Institute of India DTP Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Johnson & Johnson DTP Vaccine Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Merck Sharp & Dohme Corp Corporation Information
Table 101. Merck Sharp & Dohme Corp Description and Business Overview
Table 102. Merck Sharp & Dohme Corp DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Merck Sharp & Dohme Corp DTP Vaccine Product
Table 104. Merck Sharp & Dohme Corp Recent Developments/Updates
Table 105. Seqirus Corporation Information
Table 106. Seqirus Description and Business Overview
Table 107. Seqirus DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Seqirus DTP Vaccine Product
Table 109. Seqirus Recent Developments/Updates
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Pfizer DTP Vaccine Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Astrazeneca Corporation Information
Table 116. Astrazeneca Description and Business Overview
Table 117. Astrazeneca DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Astrazeneca DTP Vaccine Product
Table 119. Astrazeneca Recent Developments/Updates
Table 120. astellas Corporation Information
Table 121. astellas Description and Business Overview
Table 122. astellas DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. astellas DTP Vaccine Product
Table 124. astellas Recent Developments/Updates
Table 125. Emergent BioSolutions Inc Corporation Information
Table 126. Emergent BioSolutions Inc Description and Business Overview
Table 127. Emergent BioSolutions Inc DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Emergent BioSolutions Inc DTP Vaccine Product
Table 129. Emergent BioSolutions Inc Recent Developments/Updates
Table 130. WALVAX Corporation Information
Table 131. WALVAX Description and Business Overview
Table 132. WALVAX DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. WALVAX DTP Vaccine Product
Table 134. WALVAX Recent Developments/Updates
Table 135. Wuhan Institute of Biological Products Co.,Ltd. Corporation Information
Table 136. Wuhan Institute of Biological Products Co.,Ltd. Description and Business Overview
Table 137. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product
Table 139. Wuhan Institute of Biological Products Co.,Ltd. Recent Developments/Updates
Table 140. Chengdu Institute of Biological Products Co.,Ltd. Corporation Information
Table 141. Chengdu Institute of Biological Products Co.,Ltd. Description and Business Overview
Table 142. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product
Table 144. Chengdu Institute of Biological Products Co.,Ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. DTP Vaccine Distributors List
Table 148. DTP Vaccine Customers List
Table 149. DTP Vaccine Market Trends
Table 150. DTP Vaccine Market Drivers
Table 151. DTP Vaccine Market Challenges
Table 152. DTP Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DTP Vaccine
Figure 2. Global DTP Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global DTP Vaccine Market Share by Type in 2022 & 2029
Figure 4. Pertussis Product Picture
Figure 5. Diphtheria Product Picture
Figure 6. Tetanus Product Picture
Figure 7. Global DTP Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global DTP Vaccine Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Epidemic Prevention Station
Figure 11. Village Health Room
Figure 12. Global DTP Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global DTP Vaccine Market Size (2018-2029) & (US$ Million)
Figure 14. Global DTP Vaccine Sales (2018-2029) & (Units)
Figure 15. Global DTP Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 16. DTP Vaccine Report Years Considered
Figure 17. DTP Vaccine Sales Share by Manufacturers in 2022
Figure 18. Global DTP Vaccine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest DTP Vaccine Players: Market Share by Revenue in 2022
Figure 20. DTP Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global DTP Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America DTP Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America DTP Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. United States DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe DTP Vaccine Sales Market Share by Country (2018-2029)
Figure 27. Europe DTP Vaccine Revenue Market Share by Country (2018-2029)
Figure 28. Germany DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific DTP Vaccine Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific DTP Vaccine Revenue Market Share by Region (2018-2029)
Figure 35. China DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America DTP Vaccine Sales Market Share by Country (2018-2029)
Figure 45. Latin America DTP Vaccine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa DTP Vaccine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa DTP Vaccine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE DTP Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of DTP Vaccine by Type (2018-2029)
Figure 55. Global Revenue Market Share of DTP Vaccine by Type (2018-2029)
Figure 56. Global DTP Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of DTP Vaccine by Application (2018-2029)
Figure 58. Global Revenue Market Share of DTP Vaccine by Application (2018-2029)
Figure 59. Global DTP Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 60. DTP Vaccine Value Chain
Figure 61. DTP Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒト用ワクチンのグローバル市場展望 2023年-2029年：水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、ロタワクチン
  • VLPベースワクチンの世界市場2023年：弱毒生ワクチン、不活化ワクチン、組換えワクチン、トキソイドワクチン
  • 小児用ジフテリア破傷風百日咳混合ワクチン の世界市場2023年：DTwP、DTaP
  • 結核病ワクチンの世界市場2023年：予防ワクチン、曝露後ワクチン、その他
  • BCGワクチンの世界市場2023年：免疫、治療
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8747 )"DTPワクチンの世界市場2023年：百日咳、ジフテリア、破傷風" (英文：Global DTP Vaccine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。